EGFR NP_005219.2:p.L858R
1 clinical trials · Condition
◉ Watch EGFR NP_005219.2:p.L858R
| Record | Firm | Date |
|---|---|---|
| Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations (NCT01532089) | Academic and Community Cancer Research United | 2012-03-16 |
Track EGFR NP_005219.2:p.L858R automatically
Every clearance here is in the API, with alerts when new ones post.